Displaying 51 - 60 of 13638
Drupal spam blocked by CleanTalk.
Author yearsort descending
Host immune status-specific production of gliotoxin and bis-methyl-gliotoxin during invasive aspergillosis in mice. Sugui JA, Rose SR, Nardone G, Swamydas M, Lee CR, Kwon-Chung KJ, Lionakis MS. 2017
Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients. Silveira MLC, Anselmo-Lima WT, Faria FM, Queiroz DLC, Nogueira RL, Leite MGJ, Lessa RM, Simões BP, Tamashiro E, Valera FCP. 2019
Fungal infection in lung transplant recipients in perioperative period from one lung transplant center. Qiao W, Zou J, Ping F, Han Z, Li L, Wang X. 2019
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Adler-Moore J, Lewis RE, Brüggemann RJM, Rijnders BJA, Groll AH, Walsh TJ. 2019
In vitro and in vivo Efficacy of a Synergistic Combination of Itraconazole and Verapamil Against Aspergillus fumigatus. Zeng Q, Zhang Z, Chen P, Long N, Lu L, Sang H. 2019
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspective. Lagrou K, Duarte RF, Maertens J. 2019
Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatment. Barnes R, Rogers T, Maertens J 2019
Mycology Laboratory Diagnostic Capacity for Invasive Fungal Diseases in 2017: Results of a National Survey. Schelenz S, Owens K, Guy R, Rautemaa-Richardson R, Manuel RJ, Richardson M, Moore C, Enoch DA, Micallef C, Howard P, Agrawal SG, Johnson EM, Muller-Pebody B; English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). 2019
Chronic Rhinosinusitis-Could Phenotyping or Endotyping Aid Therapy? Bayar Muluk N, Cingi C, Scadding GK, Scadding G. 2019
Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Wei A, Wang K, Wang Y, Gong L, Xu J, Shao T. 2019


Subscribe to Search